PMU-Autor/inn/en
Grunze HeinzAbstract
Anticonvulsant drugs are widely used in psychiatric indications. These include mainly alcohol and benzodiazepine withdrawal syndromes, panic and anxiety disorders, dementia, schizophrenia, affective disorders, bipolar affective disorders in particular, and, to some extent, personality disorders. A further area in which neurology and psychiatry overlap is pain conditions, in which some anticonvulsants, and also typical psychiatric medications such as antidepressants, are helpful. From the beginning of their psychiatric use, anticonvulsants have also been used to ameliorate specific symptoms of psychiatric disorders independently of their causality and underlying illness, eg, aggression, and, more recently, cognitive impairment, as seen in affective disorders and schizophrenia. With new anticonvulsants currently under development, it is likely that their use in psychiatry will further increase, and that psychiatrists need to learn about their differential efficacy and safety profiles to the same extent as do neurologists.
Useful keywords (using NLM MeSH Indexing)
Anticonvulsants/pharmacology*
Anticonvulsants/therapeutic use*
Anxiety Disorders/drug therapy
Anxiety Disorders/metabolism
Anxiety Disorders/physiopathology
Bipolar Disorder/drug therapy
Bipolar Disorder/metabolism
Bipolar Disorder/physiopathology
Brain/drug effects*
Brain/metabolism
Brain/physiopathology
Humans
Mood Disorders/drug therapy
Mood Disorders/metabolism
Mood Disorders/physiopathology
Neurocognitive Disorders/drug therapy*
Neurocognitive Disorders/metabolism
Neurocognitive Disorders/physiopathology
Personality Disorders/drug therapy
Personality Disorders/metabolism
Personality Disorders/physiopathology
Schizophrenia/drug therapy
Schizophrenia/metabolism
Schizophrenia/physiopathology
Substance-Related Disorders/drug therapy
Substance-Related Disorders/metabolism
Substance-Related Disorders/physiopathology
Treatment Outcome